NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
This seems as a low risk entry here at 50 days, should rebound if the market continues higher after the previous last week pullback
The market was showing a reversal for most of Friday. Looking for a continuation on Monday.
IBD rating of 98
RS rating 94
Long @ 610.37

Keep it simple: price action and volume
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.